Perritt Capital Management Inc Chembio Diagnostics, Inc. Transaction History

Perritt Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $88,274 - $172,871	-30,651 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $87,333 - $159,579	-21,249 Reduced 40.94%	30,651 $146,000
Q3 2020 Nov 16, 2020	BUY	$3.28 - $5.93 $6,560 - $11,860	2,000 Added 4.01%	51,900 $252,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $158,682 - $775,446	49,900 New	49,900 $162,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perritt Capital Management Inc with notifications on news.